pluripotent stem cell-derived progenitor cell therapy (Assistance Publique - Hôpitaux de Paris)

N/A

Report date: 2025/06/11 10:57:48

Base Information

Drug Namepluripotent stem cell-derived progenitor cell therapy (Assistance Publique - Hôpitaux de Paris)
Drug Alias Nameextracellular vesicle enriched secretome of cardiovascular progenitor cells (Assistance Publique - Hôpitaux de Paris)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAssistance Publique Hopitaux De Paris
China Registration ClassN/A

Develop Information

Active CompaniesAssistance Publique Hopitaux De Paris
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A